News
15.12.2020 - Pharmacy
FDA Warning Letter
The FDA (U.S. Food and Drug Administration) in the USA regularly issues so-called Warning Letters to food and drug manufacturers. These Warning Letters are issued in the event of significant deviations in the manufacturing process or insufficient responses from producers following minor deficiencies.
In a recent case for a pharmaceutical company, such a letter was issued due to inadequate analytical testing in the context of goods receipt inspection and massive violations of good manufacturing practice (GMP). Purchased materials were not adequately analytically tested (purity and content) before use.
The BAV Institute within the international Tentamus Laboratory Group supports you with all necessary analytical tests in the context of pharmaceutical manufacturing. In our GMP-certified testing laboratories, we are fast and reliable for you.
You can view all Warning Letters at the following link:
For questions, our customer advisors are always available to assist you.